 |
市場調查報告書
商品編碼
1674336
TCV 疫苗市場按疫苗品牌、通路和地區分類TCV Vaccines Market, By Vaccine Brand (Ty21a (Vivotif), ViCPS (Typhim Vi), Vi-TT (Peda-typhTM), and Typbar TCV), By Distribution Channel (Public and Private), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa) |
||||||
2025 年全球 TCV 疫苗市場規模估計為 4.649 億美元，預計到 2032 年將達到 10.675 億美元，2025 年至 2032 年的複合年成長率為 12.6%。
| 報告範圍 | 報告詳細資訊 | ||
|---|---|---|---|
| 基準年 | 2024 | 2025 年市場規模 | 4.649億美元 |
| 效能資料 | 2020-2024 | 預測期 | 2025-2032 |
| 預測期：2025 年至 2032 年複合年成長率 | 12.60％ | 2032 年金額預測 | 10.675億美元 |
由於疾病和感染疾病率的不斷上升，TCV 疫苗市場在過去幾年一直穩步成長。 TCV 疫苗針對的是破傷風、白喉和百日咳等高度傳染性的細菌性呼吸道疾病。百日咳對嬰兒和幼兒尤其危險，這是全球疫苗接種計畫的主要動力。破傷風和白喉疫苗接種覆蓋率在世界範圍內很高，但百日咳仍在學校和社區中蔓延，需要常規接種疫苗。開發中國家對疫苗接種益處的認知不斷提高，政府加強常規免疫計畫的措施正在增加市場收益。最近的新產品核可和評估擴大適應症的大規模臨床試驗為該市場提供了進一步的成長機會。
市場動態
由於新興市場的需求不斷增加以及全球疫苗接種計劃的擴大，TCV 疫苗市場預計將繼續保持強勁成長。推動市場發展的關鍵因素包括父母意識的不斷增強、國際衛生組織對保護弱勢群體的建議日益增多以及政府對中低收入國家的補貼和資助。然而，聯合疫苗的研究、開發、生產和分發高成本，對疫苗的普及構成了重大挑戰。此外，由於錯誤訊息和宗教信仰而導致的疫苗猶豫正在阻礙一些國家的市場潛力。
研究的主要特點
本報告對全球 TCV 疫苗市場進行了詳細分析，並以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模和年複合成長率（CAGR%）。
它還強調了各個領域的潛在商機並解釋了該市場的有吸引力的投資提案矩陣。
它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
全球 TCV 疫苗市場的主要企業是根據公司亮點、產品系列、關鍵亮點、績效和策略等參數列出的。
主要企業包括 GSK plc.、Sanofi、Bharat BIoTech、BioFarma、Zydus Group、Emergent BioSolutions Inc.、Bavarian Nordic Inc.、Crucell Switzerland LTD.、PaxVax, Inc. 和 BIO-MED。
本報告中的見解將使負責人和企業經營團隊能夠就未來產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
全球 TCV 疫苗市場報告針對該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過全球 TCV 疫苗市場分析中使用的各種策略矩陣更輕鬆地做出決策。
目錄
第1章 調查目的與前提條件
- 研究目標
- 先決條件
- 簡稱
第2章 市場展望
- 報告描述
- 市場定義和範圍
- 執行摘要
第3章市場動態、法規與趨勢分析
- 市場動態
- 影響分析
- 監管情景
- 產品發布/核准
- PEST分析
- 波特分析
- 併購情景
- 市場趨勢
- 流行病學
4. 2020 年至 2032 年全球 TCV 疫苗市場（依疫苗品牌分類）
- 介紹
- Ty21a (Vivotiv)
- ViCPS (傷寒 Vi)
- Vi-TT (教學法)
- 類型 條形 TCV
5. 2020 年至 2032 年全球 TCV 疫苗市場依通路分類
- 介紹
- 公共
- 聯合國兒童基金會
- 競標（政府）
- 私人的
6.全球TCV 疫苗市場，依地區、價值，2020 年至 2032 年
- 介紹
- 北美洲
- 拉丁美洲
- 歐洲
- 亞太地區
- 中東
- 非洲
第7章 競爭格局
- GSK plc.
- Sanofi
- Bharat BIoTech
- BioFarma
- Zydus Group
- Emergent BioSolutions Inc.
- Bavarian Nordic Inc.
- Crucell Switzerland LTD.
- PaxVax, Inc.
- BIO-MED
第 8 章分析師建議
- 興衰
- 一致的機會地圖
第9章參考文獻與調查方法
- 參考
- 調查方法
- 關於出版商
Global Tcv Vaccines Market is estimated to be valued at USD 464.9 Mn in 2025 and is expected to reach USD 1,067.5 Mn by 2032, growing at a compound annual growth rate (CAGR) of 12.6% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 464.9 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 12.60% | 2032 Value Projection: | USD 1,067.5 Mn |
The TCV vaccines market has been witnessing steady growth over the past few years due to increasing incidence of diseases and infections. TCV vaccines target tetanus, diphtheria, and pertussis/whooping cough which are highly infectious bacterial respiratory diseases. Pertussis is especially dangerous for infants and young children which has been a key factor driving vaccination programs globally. While tetanus and diphtheria vaccination rates are high worldwide, pertussis continues to spread in schools and communities necessitating regular booster doses. Growing awareness about benefits of immunization and government efforts to strengthen routine immunization programs in developing countries have boosted market revenues. Recent new product approvals and large clinical trials evaluating expansion of indication have further widened growth opportunities in this market.
Market Dynamics:
TCV vaccines market is expected to witness robust growth going forward on account of rising demand from developing regions and increasing coverage of vaccination programs worldwide. The key drivers fueling the market include growing awareness among parents, expanding recommendation by international health organizations to protect vulnerable population groups, and government subsidies and funding in low and middle income nations. However, high costs associated with R&D, manufacturing, and distribution of combination vaccines pose a major challenge to adoption rates. In addition, ongoing vaccine hesitancy due to misinformation and religious beliefs inhibits market potential in some countries.
Key Features of the Study:
This report provides in-depth analysis of the global TCV vaccines market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global TCV vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include GSK plc., Sanofi, Bharat Biotech, BioFarma, Zydus Group, Emergent BioSolutions Inc., Bavarian Nordic Inc., Crucell Switzerland LTD., PaxVax, Inc., and BIO-MED
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global TCV vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global TCV vaccines market
Market Segmentation
- By Vaccine Brand Insights (Revenue, USD Mn, 2020 - 2032)
- Ty21a (Vivotif)
- ViCPS (Typhim Vi)
- Vi-TT (Peda-typhTM)
- Typbar TCV
- By Distribution Channel Insights (Revenue, USD Mn, 2020 - 2032)
- Public
- UNICEF
- Tender (Govt.)
- Private
- Regional Insights (Revenue, USD Mn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- GSK plc.
- Sanofi
- Bharat Biotech
- BioFarma
- Zydus Group
- Emergent BioSolutions Inc.
- Bavarian Nordic Inc.
- Crucell Switzerland LTD.
- PaxVax, Inc.
- BIO-MED
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- TCV Vaccines Market, By Vaccine Brand
- TCV Vaccines Market, By Distribution Channel
- TCV Vaccines Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Market Trends
- Epidemiology
4. Global TCV Vaccines Market, By Vaccine Brand, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Ty21a (Vivotif)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- ViCPS (Typhim Vi)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Vi-TT (Peda-typhTM)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Typbar TCV
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
5. Global TCV Vaccines Market, By Distribution Channel, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Public
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- UNICEF
- Tender (Govt.)
- Private
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
6. Global TCV Vaccines Market, By Region, 2020 - 2032, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2025,2028 & 2032, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Vaccine Brand, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Vaccine Brand, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Vaccine Brand, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Vaccine Brand, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Vaccine Brand, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Vaccine Brand, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
7. Competitive Landscape
- GSK plc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sanofi
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bharat Biotech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- BioFarma
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Zydus Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Emergent BioSolutions Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bavarian Nordic Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Crucell Switzerland LTD.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- PaxVax, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- BIO-MED
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
8. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
9. References and Research Methodology
- References
- Research Methodology
- About us
聯合脊髓灰質炎疫苗市場按疫苗類型、接種途徑、技術、新興市場發展階段和最終用戶分類 - 2025-2030 年全球預測
狂犬病疫苗市場報告：趨勢、預測和競爭分析（至 2031 年）
預防疫苗市場按疫苗類型、疾病類型、分銷管道和地區分類人類狂犬病疫苗市場：按細胞株類型、給藥途徑、應用、分銷管道 - 全球預測 2025-2030
獸用狂犬病疫苗市場、機會、成長動力、產業趨勢分析與預測，2024-2032狂犬病疫苗市場 - 按產品類型 [嬰兒倉鼠腎 (BHK)、Vero 細胞狂犬病疫苗]、類型（人用、獸用）、應用（暴露前預防、暴露後預防）、配銷通路、全球預測（2024 年- 2032 年）狂犬病疫苗市場，按產品類型、應用、預防類型、最終用戶、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測
狂犬病疫苗市場：按產品類型、按預防類型、按應用、按最終用戶：2023-2032 年全球機會分析和產業預測百日咳疫苗市場報告：2030 年趨勢、預測與競爭分析滅活脊髓灰質炎·狂犬病(恐水症)疫苗市場:疫苗，各滅活方法，各年齡層，各流通管道，各地區- 市場規模，佔有率，展望，機會分析，2023年～2030年